Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025PatientOpen Access

A Qualitative Study on Patient Experience with Signs, Symptoms, and Daily Impacts of Immune Thrombocytopenia

View Full Paper
Ask AI
Bookmark
Share

Authors

WGWaleed GhanimaNCNichola CooperSBSylvie Bozzi

Discussion

Loading...

Member takes

Overview

Qualitative analysis reveals significant symptoms and daily impacts of immune thrombocytopenia, suggesting a need for improved patient care.

Key Points

  • Six key symptoms of immune thrombocytopenia were identified, including fatigue and bruising, indicating severe patient distress.
  • Analysis involved 18 patients, with symptoms affecting over 50% of them, underscoring the disorder's profound impact on daily life.
  • The study employed concept elicitation interviews to gather patient perspectives on signs and symptoms of immune thrombocytopenia.
  • These findings highlight the urgency of integrating patient experiences into treatment strategies for immune thrombocytopenia.

Cite This Study

Ghanima et al. (2025) studied this question.

synapsesocial.com/papers/68c1c64554b1d3bfb60f2934https://doi.org/10.1007/s40271-025-00762-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI)2021 · 16 citations
  2. 2Patient survey in immune thrombocytopenia (<scp>ITP</scp>): Identifying unmet needs related to treatment and disease control in patients living in the United States2025 · 2 citations
  3. 3Association Between Bleeding Severity and Quality of Life in Adults with Immune Thrombocytopenia2026
  4. 4Patient-centric care in primary immune thrombocytopenia (ITP): shared decision-making and assessment of health-related quality of life2024 · 4 citations
  5. 5Plasma Interleukin-12 Levels as a Potential Biomarker of Fatigue and Quality of Life in Primary Immune Thrombocytopenia2025